CPC Subgroup
A61K 40/10 characterised by the cell type used
Full Title
Cellular immunotherapy (medicinal preparations containing antigens or antibodies A61K39/00) > characterised by the cell type used
5 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 40/11 T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A61K 40/13 B-cells
- A61K 40/15 Natural-killer [NK] cells; Natural-killer T [NKT] cells
- A61K 40/17 Monocytes; Macrophages
- A61K 40/19 Dendritic cells
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513